Suchergebnisse - "Silingardi, Mauro"

PubPharm (58)

1

Prospective Study of Sars-cov2 Associated Coagulopathy and Role of Complement Activation

enthalten in: ResearchSquare.com | 2024

von Silingardi, M. | Zappulo, F. | Dormi, A. | +11

2

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients : a case report

enthalten in: Journal of medical case reports | 2023

von Dalmastri, V. | Angelini, A. | Minerva, V. | +6

3

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

enthalten in: Journal of medical case reports | 2023

von Dalmastri, V. | Angelini, A. | Minerva, V. | +6

4

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

enthalten in: Journal of medical case reports | 2023

von Dalmastri, V. | Angelini, A. | Minerva, V. | +6

5

Venous thromboembolism secondary to hospitalization for COVID-19 : patient management and long-term outcomes

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Ageno, W. | Antonucci, E. | Poli, D. | +70

6

Does COVID-19 vaccination protect against pulmonary embolism?

enthalten in: Journal of anesthesia, analgesia and critical care | 2023

von Tantillo, S. | Cilloni, N. | Guarnera, M. | +5

7

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis : randomised controlled trial

enthalten in: BMJ (Clinical research ed.) | 2022

von Ageno, W. | Bertù, L. | Bucherini, E. | +43

CommentIn: Ann Intern Med. 2023 Apr;176(4):JC42. - PMID 37011394

8

Is SARS-CoV-2 infection an emerging risk factor for splanchnic venous thrombosis?

enthalten in: Clinical hemorheology and microcirculation | 2021

von Tripolino, C. | Pizzini, A. | Zaccaroni, S. | +6

9

Could Duplex carotid ultrasound be useful in the assessment of volume status and fluid responsiveness?

enthalten in: European journal of internal medicine | 2020

von Parenti, N. | Bastiani, L. | Palazzi, C. | +2

10

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders : a post hoc analysis of the DULCIS study

enthalten in: Internal and emergency medicine | 2020

von Palareti, G. | Legnani, C. | Antonucci, E. | +57

CommentIn: Intern Emerg Med. 2019 Nov;14(8):1213-1215. - PMID 31428920

1
2
3
4
5
6
Nächster »
[6]